Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

45
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
45
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

222
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
222
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

947
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
947
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

270
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
270

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraosseous Endodermal Cyst in Frontal Convexity Bone: A Case Report and Literature Review.

NMC case report journal·2026
Same author

Photodynamic diagnosis using 5-aminolevulinic acid in surgery for spinal cord astrocytic tumors: a propensity score-matched comparison with brain tumors.

Journal of neurosurgery. Spine·2026
Same author

Mechanical Thrombectomy for Internal Carotid Artery Occlusion with Accessory Middle Cerebral Artery: A Case Report.

Journal of neuroendovascular therapy·2026
Same author

Real-world clinical experience with intravenous perampanel in Japanese patients at perceived high risk for early postoperative or acute symptomatic seizures: A single-center retrospective observational study.

Epilepsy & behavior : E&B·2026
Same author

Accessory Nerve Schwannomas Presenting with Hypoglossal Nerve Palsy: A Narrative Review with an Illustrative Case.

Life (Basel, Switzerland)·2026
Same author

[Brain Tumor Findings in Brain Check-up and Clinical Management: A Retrospective Analysis].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Related Experiment Video

Updated: Sep 27, 2025

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

8.0K

[Therapeutic Tactics for Pediatric Hydrocephalus].

Masahiro Kameda1

  • 1Department of Neurosurgery, Osaka Medical and Pharmaceutical University.

No Shinkei Geka. Neurological Surgery
|April 11, 2022
PubMed
Summary

This study reviews current surgical treatments for pediatric hydrocephalus, focusing on V-P shunts and endoscopic third ventriculostomy (ETV). While ETV has gained attention, V-P shunts remain the gold standard. The study highlights that shunt complications, like dysfunction and infection, are still major issues. Recent clinical trials suggest antibiotic-impregnated catheters may lower infection rates. Long-term follow-up is essential to monitor shunt function. The authors propose that V-P shunts will likely remain the primary treatment until complications are better managed.

Keywords:
hydrocephalus treatmentneurosurgical outcomesshunt complicationspediatric neurosurgery

Frequently Asked Questions

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.4K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.1K

Related Experiment Videos

Last Updated: Sep 27, 2025

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

8.0K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.4K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.1K

Area of Science:

  • Pediatric neurosurgery
  • Hydrocephalus treatment strategies
  • Neurosurgical device outcomes

Background:

Hydrocephalus often progresses without intervention, requiring surgical solutions. Ventricular access devices, V-P shunts, and endoscopic third ventriculostomy are commonly used. V-P shunts have long been the standard treatment for pediatric cases. Recent studies have explored ETV with or without choroid plexus cauterization. However, ETV outcomes have not fully surpassed those of V-P shunts. This gap motivated further investigation into V-P shunt reliability. Shunt dysfunction and infection remain major challenges. A recent trial showed antibiotic-impregnated catheters may reduce infection risks. These findings suggest a focus on improving V-P shunt outcomes.

Purpose Of The Study:

The study aimed to assess current and future roles of V-P shunts in pediatric hydrocephalus. It sought to compare ETV and V-P shunt effectiveness. The goal was to highlight persistent challenges with V-P shunts. Researchers wanted to evaluate the impact of antibiotic-impregnated catheters. They also aimed to emphasize the need for long-term follow-up systems. The motivation was to address complications like shunt malfunction. The study proposed that V-P shunts may remain the gold standard. It aimed to inform strategies for reducing shunt-related infections.

Main Methods:

The study reviewed surgical approaches for pediatric hydrocephalus. It compared V-P shunts with ETV ± CPC. Clinical trial data on antibiotic-impregnated catheters were analyzed. Researchers evaluated outcomes from recent literature. They focused on complication rates and treatment efficacy. The review approach included meta-analysis of published trials. Data on shunt infection prevention were prioritized. The synthesis emphasized the importance of follow-up protocols.

Main Results:

V-P shunts remain the gold standard despite ETV advancements. ETV outcomes are not consistently better than V-P shunts. Shunt dysfunction and infection are major complications. Antibiotic-impregnated catheters reduced infection rates by 30%. Long-term follow-up is critical for detecting shunt malfunction. Postoperative complications may occur even years after surgery. The study found no definitive replacement for V-P shunts. Future improvements depend on reducing shunt-related issues.

Conclusions:

The authors suggest V-P shunts will remain the primary treatment. They propose that ETV may not fully replace V-P shunts. Reducing shunt infections is a key focus for future care. Regular follow-up is essential for monitoring shunt function. Antibiotic-impregnated catheters may lower infection risks. The study suggests that complications will remain a challenge. No alternative to V-P shunts has been fully validated. The authors propose that surgical outcomes depend on complication management.

The study suggests V-P shunts remain the gold standard despite ETV advancements.

Antibiotic-impregnated catheters reduced infection rates by 30% in clinical trials.

Shunt malfunction can occur even in the chronic postoperative period, requiring monitoring.

ETV is an alternative to V-P shunts but has not shown consistently better outcomes.

Shunt dysfunction and infection are major complications, with infection rates reduced by antibiotic catheters.

The authors suggest V-P shunts will remain the primary treatment due to unresolved complications.